AERI stock news

Aerie (AERI) delivered earnings and revenue surprises of 8.05% and 8.47%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
Aerie (AERI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) Akero Therapeutics Inc (NASDAQ: AKRO ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM )( IPOed June 18) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) VolitionRX Ltd (NYSE: VNRX ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 23) Abbott Laboratories (NYSE: ABT ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Advaxis, Inc. (NASDAQ: ADXS )(announced pricing of its 9.2 million common stock offering) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Apollo Endosurgery Inc (NASDAQ: APEN )(slipped ahead of earnings) Applied DNA Sciences Inc (NASDAQ: APDN ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Cancer Genetics Inc (NASDAQ: CGIX ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kindred Biosciences Inc (NASDAQ: KIN ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS )( announced data from a late-stage study of postpartum depression drug) MEI Pharma Inc (NASDAQ: MEIP ) ) Myovant Sciences Ltd (NYSE: MYOV )(announced positive late-stage trial results for drug to treat uterine fibroids and heavy menstrual bleeding) Neon Therapeutics Inc (NASDAQ: NTGN ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Psychemedics Corp. Read more
Aerie (AERI) completes enrollment in mid-stage study on Rhopressa in Japan much ahead of schedule. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 8) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Inspire Medical Systems Inc (NYSE: INSP ) (announced UnitedHealth Group Inc (NYSE: UNH ) coverage for Inspire therapy for the treatment of obstructive sleep apnea) Sol Gel Technologies Ltd (NASDAQ: SLGL )( reported positive results for late-stage trials that evaluated its Epsolay microencapsulated benzoyl peroxide cream, 5%, in papulopustular rosacea. Down In The Dumps (Biotech stocks hitting 52-week lows on July 8) Advaxis, Inc. (NASDAQ: ADXS ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Evolent Health Inc (NYSE: EVH ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Harvard Bioscience, Inc. (NASDAQ: HBIO )(announced departure of CEO Jeffrey Duchemin) Heat Biologics Inc (NASDAQ: HTBX ) Jaguar Health Inc (NASDAQ: JAGX ) Myovant Sciences Ltd (NYSE: MYOV ) Nuvectra Corp (NASDAQ: NVTR ) Puma Biotechnology Inc (NASDAQ: PBYI ) Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Coherus Biosciences Inc (NASDAQ: CHRS )(announced that it has produced over 400,000 Udenyca pre-filled syringes to date) Fate Therapeutics Inc (NASDAQ: FATE ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Misonix, Inc. (NASDAQ: MSON ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Morphic Holding Inc (NASDAQ: MORF )(IPOed June 27) Odonate Therapeutics Inc (NASDAQ: ODT ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) ResMed Inc. (NYSE: RMD ) Tricida Inc (NASDAQ: TCDA ) Vapotherm Inc (NYSE: VAPO ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 1) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Artelo Biosciences Inc (NASDAQ: ARTL ) CELLECT … Read more
AbbVie's recent deal for the pharmaceutical company Allergan is the latest in a string of healthcare M&A this year that has shifted the pharmaceutical industry's landscape. AbbVie is betting on Allergan's cosmetic products, like Botox, and other medical areas like women's health, neuroscience, eye care, and more. Analysts at Stifel say four biotechs could also be the next takeover targets: Revance Therapeutics, TherapeuticsMD, Aerie Pharmaceuticals, and Kala Pharmaceuticals. Click here for more BI Prime stories. US drugmaker AbbVie just announced a mega-deal to buy pharmaceutical company Allergan for about $63 billion. It's only the latest in a string of active healthcare deals this year , with Bristol-Myers Squibb's $74 billion proposed acquisition of Celgene and Eli Lilly's $8 billion agreement to buy the biotech Loxo Oncology in January. With Tuesday's deal, AbbVie is betting on Allergan cosmetic products like the well-known filler Botox and fat-freezing procedure CoolSculpting. But the drugmaker also clearly values Allergan's other medical treatments in areas like women's health, neuroscience, eye care and more, noted Stifel analysts Annabel Samimy and Nick Runibo. "This demonstration of interest could bring a host of other transactions that complement and build on franchises that [AbbVie] appears more committed to than [Allergan] has been," they said. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 25) ArQule, Inc. (NASDAQ: ARQL ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 25) AbbVie Inc (NYSE: ABBV )(announced a deal to buy Allergan plc (NYSE: AGN ) for $63 billion) Acer Therapeutics Inc (NASDAQ: ACER )(The FDA issued complete response letter to its rare disease drug Edsivo) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aldeyra Therapeutics Inc (NASDAQ: ALDX )( reported negative results for the late-stage study that evaluated its reproxalap in anterior uveitis) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Axcella Health Inc (NASDAQ: AXLA ) Biopharmx Corp NYSE: (BPMX) (reported positive results for a Phase 2b clinical trial of BPX-04 in treating moderate-to-severe papulopustular rosacea) CELYAD SA/ADR (NASDAQ: CYAD ) Conatus Pharmaceuticals Inc (NASDAQ: CNAT )( announced decision to explore strategic alternatives following failed NASH drug trial) Enochian Biosciences Inc (NASDAQ: ENOB ) Evolent Health Inc (NYSE: EVH ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Myriad Genetics, Inc. Read more
Aerie (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more
Aerie (AERI) reports narrower-than-expected Q1 loss. However, Rhopressa lags expectations. Read more
AERI earnings call for the period ending March 31, 2019. Read more
Aerie (AERI) delivered earnings and revenue surprises of 14.29% and -14.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Read more

Proudly made at

ROCKIT